Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies Co., Ltd. Fundamental Analysis
Meihua International Medical Technologies Co., Ltd. (MHUA) shows moderate financial fundamentals with a PE ratio of 0.34, profit margin of 10.35%, and ROE of 5.72%. The company generates $0.1B in annual revenue with weak year-over-year growth of -0.19%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 57.6/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze MHUA's fundamental strength across five key dimensions:
Efficiency Score
WeakMHUA struggles to generate sufficient returns from assets.
Valuation Score
ExcellentMHUA trades at attractive valuation levels.
Growth Score
WeakMHUA faces weak or negative growth trends.
Financial Health Score
ExcellentMHUA maintains a strong and stable balance sheet.
Profitability Score
WeakMHUA struggles to sustain strong margins.
Key Financial Metrics
Is MHUA Expensive or Cheap?
P/E Ratio
MHUA trades at 0.34 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, MHUA's PEG of -0.02 indicates potential undervaluation.
Price to Book
The market values Meihua International Medical Technologies Co., Ltd. at 0.02 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 0.56 times EBITDA. This is generally considered low.
How Well Does MHUA Make Money?
Net Profit Margin
For every $100 in sales, Meihua International Medical Technologies Co., Ltd. keeps $10.35 as profit after all expenses.
Operating Margin
Core operations generate 13.02 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $5.72 in profit for every $100 of shareholder equity.
ROA
Meihua International Medical Technologies Co., Ltd. generates $4.87 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Meihua International Medical Technologies Co., Ltd. generates limited operating cash flow of $3.69M, signaling weaker underlying cash strength.
Free Cash Flow
Meihua International Medical Technologies Co., Ltd. produces free cash flow of $3.56M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $11.24 in free cash annually.
FCF Yield
MHUA converts 1.13% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
0.34
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.02
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.02
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.04
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.07
vs 25 benchmark
Current Ratio
Current assets to current liabilities
5.71
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.06
vs 25 benchmark
ROA
Return on assets percentage
0.05
vs 25 benchmark
ROCE
Return on capital employed
0.07
vs 25 benchmark
How MHUA Stacks Against Its Sector Peers
| Metric | MHUA Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 0.34 | 29.43 | Better (Cheaper) |
| ROE | 5.72% | 800.00% | Weak |
| Net Margin | 10.35% | -20145.00% (disorted) | Strong |
| Debt/Equity | 0.07 | 0.30 | Strong (Low Leverage) |
| Current Ratio | 5.71 | 4.64 | Strong Liquidity |
| ROA | 4.87% | -17936.00% (disorted) | Weak |
MHUA outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Meihua International Medical Technologies Co., Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
7.34%
Industry Style: Defensive, Growth, Innovation
GrowingEPS CAGR
-38.03%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
38.68%
Industry Style: Defensive, Growth, Innovation
High Growth